Yahoo Web Search

  1. Acorda (ACOR) Down More Than 60% in 3 Months: Here's Why

    Zacks via Yahoo FinanceSep 03 15:00 PM

    Shares of Acorda Therapeutics, Inc. ACOR have declined sharply in the past three months. Acorda’s lead multiple sclerosis (MS) drug Ampyra is facing generic competition in the United ...

  2. Pfizer is a Top Drugmaker: Is it the Right Time to Buy It?

    Zacks via Yahoo FinanceSep 06 15:57 PM

    Pfizer, Inc. PFE is one of the biggest drugmakers in the world, boasting a diversified drug portfolio and a strong pipeline. Pfizer has a Zacks Rank #4 (Sell). Its earnings estimates ...

  3. A month has gone by since the last earnings report for Momenta Pharmaceuticals (MNTA). The company reported a loss of $1.16 per share in the quarter, wider than the Zacks Consensus Estimate ...

  4. Leaner Pfizer Positioned to Boost R&D Output

    GuruFocus.com via Yahoo FinanceSep 11 19:50 PM

    If it's true that busy hands are happy hands, then the management team at Pfizer Inc. (NYSE:PFE) must be ecstatic. Agreed to spin off Upjohn, the manufacturer of Pfizer's drugs that no ...

  5. MOVES-Credit Suisse bolsters life sciences banking team -memo

    Reuters via Yahoo FinanceSep 05 22:10 PM

    Credit Suisse Group AG has brought on three new senior investment bankers as it continues to build out its healthcare investment banking division, according to an internal memo reviewed by Reuters ...